1. Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer's Disease Studies. (20th December 2022) Authors: Grill, Joshua; Molina‐Henry, Doris P.; Sperling, Reisa A.; Dhadda, Shobha; Tranotti, Kate; Harris, Russell; Devins, Theresa; Swanson, Chad J; Kanekiyo, Michio; Gee, Michelle; Irizarry, Michael C; Kramer, Lynn D; Aisen, Paul; Raman, Rema Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022) Authors: Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 10(2022) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Strategies for diverse participant recruitment to a preclinical Alzheimer's Disease prevention trial: The AHEAD study. (20th December 2022) Authors: Molina‐Henry, Doris P.; Grill, Joshua; Sperling, Reisa A.; Aisen, Paul; Clanton, Taylor; Devins, Theresa; Dhadda, Shobha; Glover, Crystal M; Irizarry, Michael C; Johnson, Keith A.; Kirn, Dylan; Kramer, Lynn D; Shum, Leona K; Zhou, Jin; Raman, Rema Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 11 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗